Vol. 29.Issue. 5. September - October 2024 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

3.7

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

7.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.289

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.941

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 29. Issue 5.

(September - October 2024)

Editorial board

Ann Hepatol. 2024;29:101560

Full text access

Editorial

Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury

Nelia Hernandez, Fernando Bessone, Raul Andrade

Ann Hepatol. 2024;29:101520

Full text access

Concise reviews

Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting

Isabel Campos-Varela, Lluis Castells, Sergi Quiroga, Victor Vargas, Macarena Simon-Talero

Ann Hepatol. 2024;29:101515

Full text access

Original articles

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease

Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam

Ann Hepatol. 2024;29:101512

Full text access

Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referral

Hugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes

Ann Hepatol. 2024;29:101518

Full text access

Hepatitis C virus NS5A and core protein induce fibrosis-related genes regulation on Huh7 cells through activation of LX2 cells

Tania G. Heredia-Torres, Veronica Alvarado-Martínez, Ana R. Rincón-Sánchez, Sonia A. Lozano-Sepúlveda, Kame A. Galán-Huerta, Daniel Arellanos-Soto, Ana M. Rivas-Estilla

Ann Hepatol. 2024;29:101517

Full text access

The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease

Mingkai Li, Ying Lin, Hongsheng Yu, Weichun Lin, Jianning Chen, Yidong Yang, Bin Wu

Ann Hepatol. 2024;29:101516

Full text access

Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records

Ignat Drozdov, Benjamin Szubert, Ian A. Rowe, Timothy J. Kendall, Jonathan A. Fallowfield

Ann Hepatol. 2024;29:101528

Full text access

Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients

Petr Hříbek, Ondřej Vrtělka, Kateřina Králová, Johana Klasová, Markéta Fousková, Lucie Habartová, Kristýna Kubíčková, Tomáš Kupsa, ... Petr Urbánek

Ann Hepatol. 2024;29:101519

Full text access

Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct

Alan I. Valderrama-Treviño, Andrés E. Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A. Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, ... Eduardo E. Montalvo-Javé

Ann Hepatol. 2024;29:101530

Full text access

Letters to the editor

MAFLD or MASLD: Let the evidence decide again

Ziyan Pan, Mohammed Eslam

Ann Hepatol. 2024;29:101521

Full text access

MAFLD vs. MASLD: Consensus is unlike evidence!

Enas Kamal, Alaa M Mostafa, Yasser Fouad

Ann Hepatol. 2024;29:101527

Full text access

NAFLD-MASLD-MAFLD continuum: A swinging pendulum?

Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Beatriz Barranco-Fragoso, Sandra M. Barbalho, Nahum Méndez-Sánchez

Ann Hepatol. 2024;29:101526

Full text access

Hot topics in hepatology a multinational perspective

Alcohol-related liver disease: A global perspective

Graciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller

Ann Hepatol. 2024;29:101499

Full text access